Health systems are navigating a rapidly changing landscape as innovative, high-cost therapies reshape care delivery and the economics of care. These shifts are creating new opportunities for health systems to move beyond their traditional role at the end of the life sciences value chain and play a more active role upstream.
For executives, the question is no longer whether to engage, but where to play, when to act, and what to build vs. where to partner. The challenge is balancing near-term opportunities with longer-term strategic bets.
On September 10, the Chief of Medical Oncology at Duke University Health System and Chief Pharmacy Officer at WVU Medicine will share how they are approaching these decisions, including examples of building or partnering into new areas and lessons learned along the way.
Learnings include:
- What is shifting in the environment to open the door to a larger role for health systems?
- Which upstream opportunities are compelling in the near term versus over the longer term?
- What does it take operationally to turn a promising idea into something scalable and sustainable?
- How should health systems weigh building a capability internally versus partnering?